Drug & intervention
dalfampridine
RxCUI 897018
RxNorm ingredient and formulation relationships
Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.
Loading RxNorm relationships…
Clinical trials
11 shownMuscle Strain in Multiple Sclerosis Patients Measured by Ultrasound Speckle Tracking TechniqueNCT03847545 · 2018-12-12
COMPLETEDFampridine in MS Patients: A Cognition, Fatigue, Depression and Quality of Life AnalysisNCT03164018 · 2017-03-07
COMPLETEDFampridine Pregnancy Exposure RegistryNCT01532154 · 2015-08-01
TERMINATEDStudy and Treatment of Visual Dysfunction and Motor Fatigue in Multiple SclerosisNCT02391961 · 2015-04-01
COMPLETEDEfficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple SclerosisNCT02219932 · 2014-09-01
COMPLETEDA Study of the Effectiveness of Fampridine in Improving Upper Limb Function in MSNCT02208050 · 2014-02-21
COMPLETEDShort and Long Term Multiple Outcomes in Persons With Multiple Sclerosis Treated by Fampridine.NCT02849782 · 2014-02-04
COMPLETEDAn Observational Study to Collect Information on Safety and to Document the Drug Utilization of Fampyra (BIIB041) When Used In Routine Medical PracticeNCT01480063 · 2012-04-16
COMPLETEDOpen-Label Study to Assess the Effect of Long-Term Prolonged-Release Fampridine (BIIB041) on Quality of Life as Reported by Participants With Multiple SclerosisNCT01480076 · 2012-02-01
COMPLETEDEffects of Dalfampridine on Cognition in Multiple SclerosisNCT02006160 · 2011-12-01
COMPLETEDDalfampridine for Imbalance in Multiple SclerosisNCT01444300 · 2011-09-01
COMPLETEDConditions being studied
Research locations
Leading sponsors
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.